The trypanosomatids are generally aberrant in their protein N-glycosylation pathways. However, protein N-glycosylation in the African trypanosome Trypanosoma brucei, etiological agent of human African sleeping sickness, is not well understood. Here, we describe the creation of a bloodstream-form T. brucei mutant that is deficient in the endoplasmic reticulum enzyme glucosidase II. Characterization of the variant surface glycoprotein, the main glycoprotein synthesized by the parasite with two N-glycosylation sites, revealed unexpected changes in the N-glycosylation of this molecule. Structural characterization by mass spectrometry, nuclear magnetic resonance spectroscopy, and chemical and enzymatic treatments revealed that one of the two glycosylation sites was occupied by conventional oligomannose structures, whereas the other accumulated unusual structures in the form of Glc␣1-3Man␣1-2Man␣1-2Man␣1-3(Man␣1-6)Man1-4GlcNAc1-4GlcNAc, Glc␣1-3Man␣1-2Man␣1-2Man␣1-3(GlcNAc1-2Man␣1-6)Man1-4GlcNAc1-4GlcNAc, and Glc␣1-3Man␣1-2Man␣1-2Man␣1-3(Gal1-4GlcNAc1-2Man␣1-6)Man1-4GlcNAc1-4GlcNAc. The possibility that these structures might arise from Glc 1 Man 9 GlcNAc 2 by unusually rapid ␣-mannosidase processing was ruled out using a mixture of ␣-mannosidase inhibitors. The results suggest that bloodstream-form T. brucei can transfer both Man 9 GlcNAc 2 and Man 5 GlcNAc 2 to the variant surface glycoprotein in a site-specific manner and that, unlike organisms that transfer exclusively Glc 3 Man 9 GlcNAc 2 , the T. brucei UDP-Glc: glycoprotein glucosyltransferase and glucosidase II enzymes can use Man 5 GlcNAc 2 and Glc 1 Man 5 GlcNAc 2 , respectively, as their substrates. The ability to transfer Man 5 GlcNAc 2 structures to N-glycosylation sites destined to become Man 4 -3 GlcNAc 2 or complex structures may have evolved as a mechanism to conserve dolichol-phosphate-mannose donors for glycosylphosphatidylinositol anchor biosynthesis and points to fundamental differences in the specificities of host and parasite glycosyltransferases that initiate the synthesis of complex N-glycans.The parasitic protozoan Trypanosoma brucei, transmitted by the tsetse fly, is the causative agent of nagana in cattle and African trypanosomiasis or sleeping sickness in humans. During the bloodstream stage of the life cycle, the cells are covered in a densely packed coat of variant surface glycoprotein (VSG) 3 The VSG coat serves as a physical barrier to components of the host complement system and undergoes antigenic variation (1). There are many VSG genes, and each encodes a GPIanchored glycoprotein with one to three N-glycosylation sites (2, 3). The cell line used in this study expresses VSG variant 221 (also known as MiTat1.2). VSG221 carries two occupied N-glycosylation sites, the glycan structures of which have been fully characterized (4). The Asn-428 site, 5 residues from the GPI attachment site, is occupied mostly by oligomannose structures (Man 7-9 GlcNAc 2 ), whereas the Asn-263 site is occupied by small biantennary structures rangin...